Cargando…

Adjuvant therapy in colorectal cancer – studies of the FOGT group

Detalles Bibliográficos
Autores principales:	Staib, Ludger, Kornmann, Marko, Link, Karl-Heinrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254994/

Ejemplares similares

Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial
por: Thomaidis, Thomas, et al.
Publicado: (2014)

Tumor-tailored treatment of colorectal cancer: from bench to bedside?
por: Kornmann, Marko
Publicado: (2010)

Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial
por: Tikidzhieva, A, et al.
Publicado: (2012)

Are Colon and Rectal Cancer Two Different Tumor Entities? A Proposal to Abandon the Term Colorectal Cancer
por: Paschke, Stephan, et al.
Publicado: (2018)

Quality control in colon and rectal cancer surgery
por: Link, Karl-Heinrich
Publicado: (2010)

Adjuvant therapy of HER2(+ )breast cancer
por: Winer, EP
Publicado: (2009)

Adjuvant therapy after preoperative treatment for breast cancer
por: Ciruelos, E
Publicado: (2009)

Tamoxifen resistance and adjuvant hormone therapy
por: Howell, A
Publicado: (2005)

Controversies in hormonal adjuvant therapy for premenopausal patients
por: Howell, A
Publicado: (2009)

Controversies in the hormonal adjuvant therapy of postmenopausal patients
por: Dowsett, M
Publicado: (2009)

Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting?
por: Boyd, Kathleen A, et al.
Publicado: (2011)

Bisphosphonates in the adjuvant treatment of early breast cancer
por: Gnant, M
Publicado: (2009)

Monophosphoryl Lipid a as an adjuvant for immune therapy? A detailed in vitro comparison to LPS
por: Schülke, Stefan, et al.
Publicado: (2014)

Adjuvant chemotherapy for operable breast cancer: old vs new schema
por: Valagussa, P, et al.
Publicado: (2005)

Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-α
por: Kornmann, M, et al.
Publicado: (2010)

Rationale for adjuvant measures in musculoskeletal diseases
por: Gast, Ulf
Publicado: (2013)

Radically resected node-negative squamous cell carcinoma of thoracic esophagus: recurrence pattern and indication for adjuvant therapy
por: Fang, W, et al.
Publicado: (2013)

Screening & staging of colorectal cancer
por: Schima, Wolfgang, et al.
Publicado: (2014)

Ultrasound elastography as an adjuvant to conventional ultrasound in the preoperative assessment of axillary lymph nodes in suspected breast cancer: a pilot study
por: Taylor, K, et al.
Publicado: (2010)

Targeting mutant BRAF in colorectal cancer
por: Carroll, David, et al.
Publicado: (2013)

GUCY2C at the intersection of obesity and colorectal cancer
por: Waldman, Scott A, et al.
Publicado: (2013)

Implications of outpatient commitment and perceived coercion for stigma, quality of life and social functioning
por: Link, Bruce
Publicado: (2007)

Colorectal adenomas and cancer link to chromosome 13q22.1-13q31.3 in a large family with excess colorectal cancer
por: Neklason, Deborah W, et al.
Publicado: (2010)

Colorectal cancer in hyperplastic polyposis syndrome: In search of the polyp of origin
por: Rosty, Christophe, et al.
Publicado: (2011)

Efficacy of high-dose alkylating chemotherapy in the adjuvant treatment of HER2/neu-negative primary breast cancer: update of the Dutch randomized trial
por: Rodenhuis, S, et al.
Publicado: (2005)

A predictive model of metachronous colorectal cancer occurrence in Lynch syndrome
por: Bertario, Lucio, et al.
Publicado: (2010)

Applying Multiple Criteria Decision Analysis (MCDA) in the context of HTA: an experimental case study on metastatic colorectal cancer
por: Angelis, Aris, et al.
Publicado: (2015)

AOT and treatment engagement: evidence from interviews with consumers
por: Link, Bruce, et al.
Publicado: (2007)

Coercion: point, perception, process
por: Castille, Dorothy, et al.
Publicado: (2007)

Increased immunogenicity of HIV vaccination with constant-current electroporation and molecular adjuvants in mice and rhesus macaques
por: Hirao, Lauren, et al.
Publicado: (2006)

IL-18-based combinatorial adjuvants promote the NK-DC-mediated production of the CCR7 ligand CCL19 in lymph nodes from cancer patients
por: Wong, Jeffrey L, et al.
Publicado: (2013)

Dietary triglycerides profoundly affect oral sensitization to peanut protein in an adjuvant-free mouse model of peanut allergy
por: Eckhardt, Erik, et al.
Publicado: (2011)

Infiltration of dendritic cells and antigen uptake in the muscle after injection of HIV-1 Env gp120 in adjuvant
por: Liang, F, et al.
Publicado: (2012)

Classical versus new prognostic factors for adjuvant treatment selection based on line software to estimate risk and benefit
por: Ravdin, PM
Publicado: (2005)

Deciphering the molecular pathways disrupted in normal and neoplastic colonic tissue in inherited colorectal cancer syndromes
por: Neklason, Deborah W, et al.
Publicado: (2011)

Photodynamic therapy of laryngeal cancers
por: Biel, Merrill
Publicado: (2010)

Monoclonal antibodies for the therapy of cancer
por: Simpson, Andrew, et al.
Publicado: (2014)

Locoregional therapy of renal cancer
por: Wah, Tze Min
Publicado: (2014)

Service user groups as co-applicants on a platform study for a trial
por: Morgan, Heather, et al.
Publicado: (2013)

Virtual screening for plant PARP inhibitors – what can be learned from human PARP inhibitors?
por: Heym, Peter-Paul, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_i1ue96qb0s35959tmi53agqgir